Copyright
©2014 Baishideng Publishing Group Inc.
World J Obstet Gynecol. Nov 10, 2014; 3(4): 141-147
Published online Nov 10, 2014. doi: 10.5317/wjog.v3.i4.141
Published online Nov 10, 2014. doi: 10.5317/wjog.v3.i4.141
Ref. | Design | Sample size | Main outcome measures | Findings |
Robillard et al[20] | Case control | 74 hypertensive cases 60 controls | Change of paternity | Change of paternity was 61.7%, 10% and 16.6% inn PIH group, chronic hypertension group and controls respectively (P < 0.0001) |
Feeney et al[21] | Matched case control | 47 cases with preeclampsia 47 normotensive controls | Change of paternity | 13 cases with paternity change vs 3 controls with paternity change (P < 0.01) |
Ikedife[22] | Case series | 46 eclamptic multiparous patients | 74% of subjects had paternity change | |
Chng[23] | Case report | Case of severe preeclampsia in the patient with prior history of uneventful first pregnancy after change of paternity | ||
Tubbergen et al[24] | Retrospective case control study | 333 multiparous subjects with hypertensive disorder 182 multiparous normotensive subjects | Change of paternity | 22.6%-preeclamptic multiparas with change of paternity; 27.0%-HELLP multiparas with change of paternity; 3.3%-change of paternity among normotensive multiparas OR for preeclampsia among subjects with new partner was 8.6 (95%CI: 3.1-23.5) and for HELLP 10.9 (95%CI: 3.7-32.3) comparing to normotensive subjects |
Li et al[25] | Retrospective cohort | 140147 pregnancies | Incidence of preeclampsia/eclampsia | OR for preeclampsia among women with previous normal pregnancy and change of paternity was 1.3 (95%CI: 1.1-1.6) |
Trupin et al[26] | Prospective cohort | 5800 pregnancies | Incidence of preeclampsia | Adjusted OR for preeclampsia among multiparas with change of paternity 1.4 (95%CI: 0.8-2.4) |
Bandoli et al[27] | Prospective cohort | 1396 pregnancies | Incidence of preeclampsia | OR for preeclampsia 2.75 (95%CI: 1.33-5.68) among women with change paternity |
Verwoerd et al[28] | Case control | 60 multigravidae with preeclampsia | Change of paternity | Change of paternity was 38.3% vs 21.7% (cases vs controls) |
60 normotensive multigravidae | Uncorrected OR for preeclampsia with primipaternity 2.3 (95%CI: 0.9-5.5) | |||
Chigbu et al[29] | Prospective cohort | 732 pregnancies | Incidence of preeclampsia | Preeclampsia in 3.5% of cases vs 3.1% controls (NS) |
Saftlas et al[30] | Retrospective cohort | 4589 pregnancies | Incidence of PIH and preeclampsia | Adjusted OR for preeclampsia among women with history of abortion who conceived again with same partner 0.55 (95%CI: 0.21-0.97) |
Olayemi et al[31] | Prospective cohort | 2630 | Incidence of hypertension in pregnancy | History of same paternity abortion was protective against preeclampsia (HR = 0.46, 95%CI: 0.22-0.96) |
Ref. | Design | Sample size | Main outcome measures | Findings |
Donor oocytes | ||||
Söderström-Anttila et al[11] | Retrospective cohort | 51 oocyte donation pregnancies 97 IVF age matched controls | The incidence of PIH and preeclampsia | The incidence of PIH in primiparae was 30% in oocyte donor recipients and 13% in IVF controls (P < 0.05), no difference in preeclampsia incidence between two groups |
Salha et al[10] | Retrospective cohort | 27 donor oocytes pregnancies 27 age-and parity matched controls | The incidence of preeclampsia | Preeclampsia incidence 16% vs 3.7% (cases vs controls), P < 0.05 |
Keegan et al[38] | Retrospective anonymous questionnaire study | 199 oocyte donor recipients 488 autologous IVF controls | The incidence of PIH | Rate of pregnancy induced hypertension in < 35 years old was 42% vs 12%, P < 0.001 (cases vs controls) and > 40 years old 26% vs 14%, P = 0.003 (cases vs controls) |
Klatsky et al[9] | Retrospective matched cohort | 77 donor oocytes recipients 81 autologous IVF controls | The incidence of PIH and preeclampsia | 16.9% of cases with preeclampsia vs 4.9% controls 24.7% of cases with PIH vs 7.4 % controls Adjusted OR for preeclampsia with donor oocytes OR = 4.0 (95%CI: 1.2-13.8) and for gestational hypertension OR = 4.2 (95%CI: 1.5-11.9) |
Tranquilli et al[12] | Retrospective matched cohort | 26 donor oocytes recipients 52 autologous ICSI pregnancies 52 AMA controls | Prevalence of preeclampsia | Prevalence of preeclampsia 19.2% in donor oocyte recipients vs 0% in autologous ICSI and AMA controls (P < 0.001) |
Donor sperm | ||||
Need et al[33] | Case series | 584 AID pregnancies | The incidence of preeclampsia | Preeclampsia incidence 9.3% |
Smith et al[35] | Retrospective cohort | 37 donor insemination pregnancies 44 controls | The incidence of preeclampsia | 24.3% of cases with preeclampsia vs 6.8% controls RR for preeclampsia with donor insemination RR = 1.85 (95%CI: 1.20-2.85) |
Hoy et al[34] | Retrospective cohort | 1552 donor insemination pregnancies 7717 controls | The incidence of preeclampsia | 8.4% of cases with preeclampsia vs 5.2 % controls Adjusted OR for preeclampsia with donor insemination OR = 1.4 (95%CI: 1.2-1.8) |
Salha et al[10] | Retrospective cohort | 33 donor sperm pregnancies 33 age-and parity matched controls | The incidence of preeclampsia | Preeclampsia incidence 18.2% vs 0% (cases vs controls), P < 0.05 |
Hall et al[37] | Retrospective cohort | 45 donor insemination pregnancies 173 controls | The incidence of proteinuric hypertension | No difference in incidence of proteinuric hypertension between cases and controls (13.3% vs 11.0%) |
Kyrou et al[36] | Retrospective cohort | 438 donor insemination pregnancies 275 partner sperm | The incidence of preeclampsia | Preeclampsia incidence 10.9% vs 7.2% (cases vs controls), difference 3.7%; 95%CI: -0.8 to 7.8 |
Donor embryos | ||||
Porreco et al[39] | Retrospective cohort | 23 donor embryos pregnancies 24 age matched IVF controls | The incidence of preeclampsia | 26% of cases with preeclampsia vs 29% controls OR for preeclampsia with donor embryos OR = 0.86 (95%CI: 0.24-3.09) |
Salha et al[10] | Retrospective cohort | 12 donor embryos pregnancies 12 age-and parity matched controls | The incidence of preeclampsia | Preeclampsia incidence 25% vs 0% (cases vs controls), NS |
Ref. | Design | Sample size | Main outcome measures | Results |
Robillard et al[7] | Retrospective cohort | 1011 pregnancies | Incidence of PIH | Incidence of PIH was 10.6% (entire cohort) and 5.1% among women with > 12 mo of sexual cohabitation (11.9% and 3.3% for primigravidae, respectively) |
Verwoerd et al[28] | Case control | 60 cases with preeclampsia 60 normotensive controls | Length of sexual cohabitation | Unprotected sexual cohabitation of > 6 mo was a negative predictor for preeclampsia (coefficient -0.57, SE 0.62, P = 0.03) |
Olayemi et al[31] | Prospective cohort | 2630 pregnancies | Incidence of hypertension in pregnancy | Length of sexual cohabitation before pregnancy was protective against hypertension in pregnancy (HR = 0.96, 95%CI: 0.93-0.99) but not preeclampsia (HR = 1.07, 95%CI: 0.00-1.15) |
Kho et al[42] | Prospective cohort | 2507 pregnancies | Incidence of preeclampsia | OR for preeclampsia were 2.32 (95%CI: 1.03-5.25) and 1.88 (95%CI: 1.05-3.36) for short sexual relationship of less then 3 mo and less then 6 mo respectively |
Klonoff-Cohen et al[43] 1989 | Case control | 110 preeclamptic cases 115 normotensive controls | Contraceptive and reproductive history of subjects | OR for preeclampsia for barrier contraceptive users was 2.37 (95%CI: 1.01-5.58) |
Mills et al[44] | Merge data from two prospective cohort studies | 13914 pregnancies (total) | Incidence of preeclampsia | OR for preeclampsia in barrier contraceptive users were 0.85 (95%CI: 0.71-1.12) (one study) and 0.85 (95%CI: 0.49-1.45) (second study) |
Saftlas et al[46] | Case control | 258 cases 182 controls | Length of sexual cohabitation | OR for preeclampsia among women with long (> 90%) sexual relation-OR = 0.3 (95%CI: 0.1-0.9) |
- Citation: Breborowicz A, Klatsky P. Association between gamete source, exposure and preeclampsia: A review of literature. World J Obstet Gynecol 2014; 3(4): 141-147
- URL: https://www.wjgnet.com/2218-6220/full/v3/i4/141.htm
- DOI: https://dx.doi.org/10.5317/wjog.v3.i4.141